Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Weingessel

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Acta Ophthalmologica|April 4, 2017
Patients' maximum acceptable waiting time for cataract surgery: a comparison at two time-points 7 years apartBirgit Weingessel, Michael Wahl, Pia V Vécsei-Marlovits
Wiener Klinische Wochenschrift|March 20, 2015
Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degenerationBirgit Weingessel, Kata Mihaltz, Pia Veronika Vécsei-Marlovits
Wiener Medizinische Wochenschrift (1946)|March 31, 2017
More frequent requests for day-case cataract surgery : An impressive mind switch in the Austrian population within 7 yearsBirgit Weingessel, Michael Wahl, Pia Veronika Vécsei-Marlovits
Acta Ophthalmologica|June 10, 2010
Which factors influence patients' maximum acceptable waiting time for cataract surgery? - a questionnaire surveyBirgit Weingessel, Sibylla Richter-Mueksch, Pia V Vécsei-Marlovits
Acta Ophthalmologica|October 5, 2018
Decision-making for cataract surgery: Changes within 7 yearsBirgit Weingessel, Michael Wahl, Wolfgang Huf, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 29, 2022
Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumabAgnes Boltz, Katharina Radunsky, Birgit Weingessel, et al.
Retina (Philadelphia, Pa.)|June 8, 2015
OCULAR WAVEFRONT ABERRATIONS AND OPTICAL QUALITY IN DIABETIC MACULAR EDEMAKata Miháltz, Illés Kovács, Birgit Weingessel, et al.
Retina (Philadelphia, Pa.)|December 22, 2011
Time to first treatment: The significance of early treatment of exudative age-related macular degenerationRenate Rauch, Birgit Weingessel, Saskia M Maca, et al.
Acta Ophthalmologica|July 17, 2016
Clinical risk management - a 3-year experience of team timeout in 18 081 ophthalmic patientsBirgit Weingessel, Michaela Haas, Christina Vécsei, et al.
Journal of Ophthalmology|April 3, 2018
Comparison of Two Toric IOLs with Different Haptic Design: Optical Quality after 1 YearKata Miháltz, Michael Lasta, Michael Burgmüller, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Acta Ophthalmologica|April 4, 2017
Patients' maximum acceptable waiting time for cataract surgery: a comparison at two time-points 7 years apartBirgit Weingessel, Michael Wahl, Pia V Vécsei-Marlovits
Wiener Klinische Wochenschrift|March 20, 2015
Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degenerationBirgit Weingessel, Kata Mihaltz, Pia Veronika Vécsei-Marlovits
Wiener Medizinische Wochenschrift (1946)|March 31, 2017
More frequent requests for day-case cataract surgery : An impressive mind switch in the Austrian population within 7 yearsBirgit Weingessel, Michael Wahl, Pia Veronika Vécsei-Marlovits
Acta Ophthalmologica|June 10, 2010
Which factors influence patients' maximum acceptable waiting time for cataract surgery? - a questionnaire surveyBirgit Weingessel, Sibylla Richter-Mueksch, Pia V Vécsei-Marlovits
Acta Ophthalmologica|October 5, 2018
Decision-making for cataract surgery: Changes within 7 yearsBirgit Weingessel, Michael Wahl, Wolfgang Huf, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 29, 2022
Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumabAgnes Boltz, Katharina Radunsky, Birgit Weingessel, et al.
Retina (Philadelphia, Pa.)|June 8, 2015
OCULAR WAVEFRONT ABERRATIONS AND OPTICAL QUALITY IN DIABETIC MACULAR EDEMAKata Miháltz, Illés Kovács, Birgit Weingessel, et al.
Retina (Philadelphia, Pa.)|December 22, 2011
Time to first treatment: The significance of early treatment of exudative age-related macular degenerationRenate Rauch, Birgit Weingessel, Saskia M Maca, et al.
Acta Ophthalmologica|July 17, 2016
Clinical risk management - a 3-year experience of team timeout in 18 081 ophthalmic patientsBirgit Weingessel, Michaela Haas, Christina Vécsei, et al.
Journal of Ophthalmology|April 3, 2018
Comparison of Two Toric IOLs with Different Haptic Design: Optical Quality after 1 YearKata Miháltz, Michael Lasta, Michael Burgmüller, et al.
Pageof 3